DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 146 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 3.99 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,272,000 | +67.1% | 57,730 | +16.2% | 0.04% | +118.8% |
| Q3 2018 | $761,000 | +41.2% | 49,661 | +11.4% | 0.02% | +60.0% |
| Q2 2018 | $539,000 | -70.2% | 44,563 | -76.5% | 0.01% | -73.7% |
| Q1 2018 | $1,810,000 | +263.5% | 189,294 | +256.1% | 0.04% | +245.5% |
| Q4 2017 | $498,000 | +43.5% | 53,162 | -9.9% | 0.01% | 0.0% |
| Q3 2016 | $347,000 | -59.6% | 59,006 | -79.4% | 0.01% | -60.7% |
| Q2 2016 | $859,000 | +17.0% | 286,413 | +109.3% | 0.03% | +33.3% |
| Q1 2016 | $734,000 | +270.7% | 136,853 | +724.8% | 0.02% | +320.0% |
| Q4 2015 | $198,000 | – | 16,593 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,355,392 | $29,859,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $67,858,000 | 4.26% |
| DAFNA Capital Management LLC | 587,756 | $12,948,000 | 3.85% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 227,388 | $5,009,000 | 2.91% |
| RTW INVESTMENTS, LP | 7,253,857 | $159,802,000 | 2.68% |
| Parkman Healthcare Partners LLC | 331,513 | $7,303,000 | 1.87% |
| Evolutionary Tree Capital Management, LLC | 60,864 | $1,341,000 | 1.02% |
| Eagle Health Investments LP | 69,000 | $1,520,000 | 0.97% |
| Woodline Partners LP | 1,358,796 | $29,934,000 | 0.79% |
| Affinity Asset Advisors, LLC | 40,000 | $881,000 | 0.47% |